AR011138A1 - Compuestos derivados de 4-aminoalcoxi-1,3-dihidrobenzomidazol-2-onas, composicion farmaceutica que los comprende y uso de los mismos para lafabricacion de un medicamento util, agonistas del autorreceptor de la dopamina. - Google Patents
Compuestos derivados de 4-aminoalcoxi-1,3-dihidrobenzomidazol-2-onas, composicion farmaceutica que los comprende y uso de los mismos para lafabricacion de un medicamento util, agonistas del autorreceptor de la dopamina.Info
- Publication number
- AR011138A1 AR011138A1 ARP980100620A ARP980100620A AR011138A1 AR 011138 A1 AR011138 A1 AR 011138A1 AR P980100620 A ARP980100620 A AR P980100620A AR P980100620 A ARP980100620 A AR P980100620A AR 011138 A1 AR011138 A1 AR 011138A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- manufacture
- pharmaceutical composition
- hydrogen
- dihidrobenzomidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto derivado de 4-aminoalcoxi-1,3-dihidrobenzoimidazol-2-onas que tiene la formula (I), en la cual R1 es hidrogeno o alquilo C1-C6; R2 esseleccionada entre hidrogeno, alquilo C1-C10 de cadena recta y ramificada, ciclohexilmetilo o-(CH2)mAr, donde Ar es fenilo, naftilo, tienilo, furaniloo piridinilo, cada uno de ellos optativamente sustituido por uno o dos sustituyentes seleccionados independientemente entre alquilo C1-C6, halogeno,alcoxi C1-C6, y trifluorometilo; oN R1R2 es 1,2,3,4-tetrahidroquinolin-1-ilo o 1,2,3,4-tetrahidroisoquinolin-1-ilo; m es 1 - 5; n es 1 o 2; R3 es hidrogenoo alquilo C1-C6; Y es hidrogeno, halogeno, alquilo C1-C6; y alcoxi C1-C6, o una sal farmacéuticamente aceptable del mismo.Estos compuestos son agentesdopaminérgicos D2 utiles en el tratamiento de esquizofrenia, enfermedad de Parkinson, síndrome de Tourette, y adicion de drogas o alcohol. Ademés sedescribe una composicion farmacéutica y el uso de dichos compuestospara la manufactura de un medicamento.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80187097A | 1997-02-18 | 1997-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011138A1 true AR011138A1 (es) | 2000-08-02 |
Family
ID=25182225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980100620A AR011138A1 (es) | 1997-02-18 | 1998-02-11 | Compuestos derivados de 4-aminoalcoxi-1,3-dihidrobenzomidazol-2-onas, composicion farmaceutica que los comprende y uso de los mismos para lafabricacion de un medicamento util, agonistas del autorreceptor de la dopamina. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0964853A1 (es) |
| JP (1) | JP2001511804A (es) |
| KR (1) | KR20000071160A (es) |
| CN (1) | CN1138761C (es) |
| AR (1) | AR011138A1 (es) |
| AU (1) | AU744443B2 (es) |
| BR (1) | BR9807703A (es) |
| CA (1) | CA2278747A1 (es) |
| HU (1) | HUP0001262A3 (es) |
| IL (1) | IL131156A0 (es) |
| NZ (1) | NZ337271A (es) |
| TW (1) | TW383303B (es) |
| WO (1) | WO1998035946A1 (es) |
| ZA (1) | ZA981310B (es) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9210632D0 (en) * | 1992-05-19 | 1992-07-01 | Fisons Plc | Compounds |
| IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
| ATE210657T1 (de) * | 1994-10-14 | 2001-12-15 | Merck Patent Gmbh | Zns wirksames (r)-(-)-2-(5-(4-fluorophenyl)-3- pyridylmethylaminomethyl)chroman |
| AR004523A1 (es) * | 1995-11-06 | 1998-12-16 | American Home Prod | 2-(AMINOMETIL)-3,4,7,9-TETRAHIDRO-2H-PIRANO-[2,3e] INDOL-8-ONAS Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN |
| ATE227284T1 (de) * | 1996-08-27 | 2002-11-15 | Wyeth Corp | 4-aminoethoxy-indolonderivate als dopamin d2 agonisten |
| KR20000035818A (ko) * | 1996-08-27 | 2000-06-26 | 이곤 이 버그 | 4-아미노에톡시 인돌론 유도체 |
-
1998
- 1998-01-13 IL IL13115698A patent/IL131156A0/xx unknown
- 1998-01-13 NZ NZ337271A patent/NZ337271A/xx unknown
- 1998-01-13 JP JP53572998A patent/JP2001511804A/ja active Pending
- 1998-01-13 KR KR1019997007450A patent/KR20000071160A/ko not_active Application Discontinuation
- 1998-01-13 EP EP98903469A patent/EP0964853A1/en not_active Withdrawn
- 1998-01-13 CN CNB988041197A patent/CN1138761C/zh not_active Expired - Fee Related
- 1998-01-13 WO PCT/US1998/000623 patent/WO1998035946A1/en not_active Application Discontinuation
- 1998-01-13 AU AU60234/98A patent/AU744443B2/en not_active Ceased
- 1998-01-13 BR BR9807703-1A patent/BR9807703A/pt not_active IP Right Cessation
- 1998-01-13 HU HU0001262A patent/HUP0001262A3/hu unknown
- 1998-01-13 CA CA002278747A patent/CA2278747A1/en not_active Abandoned
- 1998-02-05 TW TW087101495A patent/TW383303B/zh not_active IP Right Cessation
- 1998-02-11 AR ARP980100620A patent/AR011138A1/es not_active Application Discontinuation
- 1998-02-17 ZA ZA9801310A patent/ZA981310B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA981310B (en) | 1999-08-17 |
| CN1252060A (zh) | 2000-05-03 |
| WO1998035946A1 (en) | 1998-08-20 |
| IL131156A0 (en) | 2001-01-28 |
| HUP0001262A2 (hu) | 2001-04-28 |
| AU6023498A (en) | 1998-09-08 |
| EP0964853A1 (en) | 1999-12-22 |
| JP2001511804A (ja) | 2001-08-14 |
| HUP0001262A3 (en) | 2002-04-29 |
| CN1138761C (zh) | 2004-02-18 |
| AU744443B2 (en) | 2002-02-21 |
| TW383303B (en) | 2000-03-01 |
| CA2278747A1 (en) | 1998-08-20 |
| BR9807703A (pt) | 2000-05-02 |
| KR20000071160A (ko) | 2000-11-25 |
| NZ337271A (en) | 2001-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20001485A1 (es) | Derivados de la camptotecina que tienen actividad antitumoral | |
| EA200200571A1 (ru) | Новая композиция и ее применение | |
| FR16C1001I1 (fr) | "Dérivé de 2-oxo-1-pyrrolidine et ses applications pharmaceutique" | |
| DK1697370T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
| DK1697371T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
| KR970704435A (ko) | 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands) | |
| PA8495101A1 (es) | Derivados de 13-metileritromicina | |
| NO963053L (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
| DE69529670D1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| AR013879A1 (es) | Compuesto parasiticida derivado pirazol, formulaciones veterinarias o agricolas y composiciones farmaceuticas que lo contienen, el uso de dicho compuesto para la manufactura de medicamentos, compuestos utiles y procedimiento para la fabricacion de dicho compuesto | |
| AR033594A1 (es) | Un compuesto derivado de 3-aroilindol, su utilizacion, procedimientos para prepararlo, una composicion farmaceutica que lo contiene, un medicamento constituido por dicho compuesto, y compuestos intermediarios | |
| SE0201544D0 (sv) | Novel compounds and thier use | |
| AR056321A1 (es) | COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS | |
| EA200000023A1 (ru) | Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола | |
| SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| RU2010116779A (ru) | Производное амида индазолакриловой кислоты | |
| AR040274A1 (es) | Derivados de 1-[(indol-3-il)carbonil]piperazina como agonistas de canabinoides en el tratamiento del dolor y composiciones farmaceuticas | |
| SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| GEP20043227B (en) | 5HT1 Antagonists for Antidepressant Therapy | |
| EE200100520A (et) | N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena | |
| AR011138A1 (es) | Compuestos derivados de 4-aminoalcoxi-1,3-dihidrobenzomidazol-2-onas, composicion farmaceutica que los comprende y uso de los mismos para lafabricacion de un medicamento util, agonistas del autorreceptor de la dopamina. | |
| ATE406363T1 (de) | Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten | |
| KR900012925A (ko) | 인돌 유도체 | |
| AR043016A2 (es) | Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene | |
| AR011136A1 (es) | Compuesto derivado 4-aminoalcoxi-1h-benzoimidazoles, composicion farmaceutica que lo contiene y el uso del mismo para la fabricacion de unmedicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |